Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Microport Cardioflow Medtech Co., Ltd.

Clinical trials sponsored by Shanghai Microport Cardioflow Medtech Co., Ltd., explained in plain language.

Now part of MicroPort CardioFlow Medtech Corporation 2160 HKEX

A medical device company developing transcatheter heart valve products, a subsidiary of MicroPort Scientific.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

Less invasive heart valve fix could rival Open-Heart surgery for tough cases

Disease control ENROLLING_BY_INVITATION

This study compares two ways to replace a narrowed heart valve in people with a bicuspid aortic valve (a common birth defect). One method is transcatheter aortic valve replacement (TAVR), a less invasive procedure using a tube inserted through a blood vessel. The other is traditi…

Phase: NA • Sponsor: Shanghai MicroPort CardioFlow Medtech Co., Ltd. • Aim: Disease control

Last updated Jun 26, 2026 18:14 UTC